• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Daniel P. Cahill, MD, PhD

Publications

  • Jones PS, Dunn GP, Barker FG, Curry WT, Hochberg FH, Cahill DP.Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th Annual Frye-Halloran Brain Tumor Symposium.Neurosurg Focus. 2013 Feb;34(2):E9.
    23373454
  • Dunn GP, Andronesi OC, Cahill DP.From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma.Neurosurg Focus. 2013 Feb;34(2):E2.
    23373447
  • Dziurzynski K, Blas-Boria D, Suki D, Cahill DP, Prabhu SS, Puduvalli V, Levine N.Butterfly glioblastomas: a retrospective review and qualitative assessment of outcomes.J. Neurooncol. 2012 Sep;109(3):555-63.
    22806339
  • Likhacheva A, Pinnix CC, Parikh NR, Allen PK, McAleer MF, Chiu MS, Sulman EP, Mahajan A, Guha-Thakurta N, Prabhu SS, Cahill DP, Luo D, Shiu AS, Brown PD, Chang EL.Predictors of Survival in Contemporary Practice After Initial Radiosurgery for Brain Metastases.Int J Radiat Oncol Biol Phys. 2012 Aug 14.
    22898384
  • Raghunathan A, Olar A, Vogel H, Parker JR, Coventry SC, Debski R, Albarracin CT, Aldape KD, Cahill DP, Powell SZ, Fuller GN.Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.Ann Diagn Pathol. 2012 Aug;16(4):255-9.
    22445362
  • Olar A, Raghunathan A, Albarracin CT, Aldape KD, Cahill DP, Powell SZ, Goodman JC, Fuller GN.Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults.Ann Diagn Pathol. 2012 Jun;16(3):161-70.
    22197544
  • Bettegowda C, Agrawal N, Jiao Y, Sausen M, Wood LD, Hruban RH, Rodriguez FJ, Cahill DP, McLendon R, Riggins G, Velculescu VE, Oba-Shinjo SM, Marie SK, Vogelstein B, Bigner D, Yan H, Papadopoulos N, Kinzler KW.Mutations in CIC and FUBP1 contribute to human oligodendroglioma.Science. 2011 Sep 9;333(6048):1453-5.
    21817013
  • Cahill DP, Barker FG, Davis KR, Kalva SP, Sahai I, Frosch MP.Case records of the Massachusetts General Hospital. Case 10-2010. A 37-year-old woman with weakness and a mass in the brain.N Engl J Med. 2010 Apr 8;362(14):1326-33.
    20375410
  • Yip S, Miao J, Cahill DP, Iafrate AJ, Aldape K, Nutt CL, Louis DN.MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.Clin Cancer Res. 2009 Jul 15;15(14):4622-9.
    19584161
  • Cahill DP, Codd PJ, Batchelor TT, Curry WT, Louis DN.MSH6 inactivation and emergent temozolomide resistance in human glioblastomas.Clin Neurosurg. 2008;55:165-71.
    19248684
  • Cahill DP, Levine KK, Betensky RA, Codd PJ, Romany CA, Reavie LB, Batchelor TT, Futreal PA, Stratton MR, Curry WT, Iafrate AJ, Louis DN.Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.Clin Cancer Res. 2007 Apr 1;13(7):2038-45.
    17404084
  • Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR.Patterns of somatic mutation in human cancer genomes.Nature. 2007 Mar 8;446(7132):153-8.
    17344846
  • Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK.AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.Cancer Cell. 2007 Jan;11(1):83-95.
    17222792
  • Hunter C, Smith R, Cahill DP, Stephens P, Stevens C, Teague J, Greenman C, Edkins S, Bignell G, Davies H, O'Meara S, Parker A, Avis T, Barthorpe S, Brackenbury L, Buck G, Butler A, Clements J, Cole J, Dicks E, Forbes S, Gorton M, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Kosmidou V, Laman R, Lugg R, Menzies A, Perry J, Petty R, Raine K, Richardson D, Shepherd R, Small A, Solomon H, Tofts C, Varian J, West S, Widaa S, Yates A, Easton DF, Riggins G, Roy JE, Levine KK, Mueller W, Batchelor TT, Louis DN, Stratton MR, Futreal PA, Wooster R.A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.Cancer Res. 2006 Apr 15;66(8):3987-91.
    16618716
  • Wang Z, Cummins JM, Shen D, Cahill DP, Jallepalli PV, Wang TL, Parsons DW, Traverso G, Awad M, Silliman N, Ptak J, Szabo S, Willson JK, Markowitz SD, Goldberg ML, Karess R, Kinzler KW, Vogelstein B, Velculescu VE, Lengauer C.Three classes of genes mutated in colorectal cancers with chromosomal instability.Cancer Res. 2004 May 1;64(9):2998-3001.
    15126332